iTAPP: Identification and Treatment of Alcohol Problems in Primary Care
Study Details
Study Description
Brief Summary
The Identification and Treatment of Alcohol Problems in Primary Care (iTAPP) Study is a pragmatic cluster randomized controlled intervention trial evaluating the effectiveness of the 15-Method as an identification and treatment tool for alcohol-related problems in Danish general practice. The 15-Method combines evidence-based approaches from specialized addiction treatment with screening and readily available treatment options in general practice to help identify and treat alcohol problems in a primary care setting. The method has shown promising results as a treatment tool in Sweden. A feasibility study of the 15-Method in Denmark suggested that the method can be implemented in Danish general practice.
The trial is led by the Unit for Clinical Alcohol Research at The University of Southern Denmark in collaboration with The Research Unit of General Practice Odense at The University of Southern Denmark.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The study protocol with a detailed description of the iTAPP Study is in preparation.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
No Intervention: Control Each participating clinic serves as its own control and as control for active clinics, in the stepped-wedge design. All clinics are inactive (no intervention) during the baseline period of three months. |
|
Active Comparator: Active Active clinics are trained in the intervention object (the 15-method) prior to switching to the active group. Clinics are enrolled as active clinics (intervention) in four steps (4-5 clinics in each step). The intervention is implemented into the clinic, and the staff are free to use the intervention in everyday work. |
Behavioral: The 15-Method
The 15-Method is a Screening and Brief Intervention method for identifying and treating alcohol problems in primary care. The method combines evidence-based approaches from specialized addiction treatment with screening and readily available treatment options in general practice to help identify and treat alcohol problems. The 15-method is based on Motivational Interviewing, Cognitive Behavioral Therapy and utilizes the Alcohol Use Disorder Identification Test (AUDIT) as a screening tool. The 15-Method contains three flexible steps: Identification of clinical problem related to alcohol; feedback and clinical work-up as needed; treatment. Treatment includes structured consultations (maximum of four) with patient home-work assignments, and can be combined with pharmacological treatment for alcohol problems.
|
Outcome Measures
Primary Outcome Measures
- Frequency of alcohol related conversations in the clinics [Up to 19 months]
The total number of consultations in which the topic of alcohol has been addressed. Outcome measure on the level of the practices (i.e. not patients). Alcohol related conversations are continuously registered in the patient filing system throughout the study period. Comparison of baseline frequency (pre-implementation) to post-implementation frequencies
Secondary Outcome Measures
- Percentage of patients who exceed the Danish national recommendations of alcohol consumption [4 times of 10 minutes]
Data type: survey Level: population Variables: The Alcohol Use Disorder Identification Test Scores (0-40 points) and the Timeline Follow Back one-week version (number of standard drinks, 12g of ethanol, per week) Comparison of baseline (pre-implementation) and post-implementation levels
- Quality of Life 5D-5L scores [4 times of 10 minutes]
Data: Survey Level: population Variable: Quality of life score by The World Health Organization 5D-5L questionnaire.
- Pharmacological Treatment [0-4 sessions of 15 minutes]
The use of pharmacological treatment for alcohol problems in the clinics will be analyzed, comparing baseline levels to active (post-implementation) levels. Data: register based Level: practices Variables: prescription rates of Disulfiram, Naltrexone, Acamprosate, and Nalmefene
- Use of blood sampling [0-4 sessions of 15 minutes]
The use of blood sampling as screening/monitoring for potential alcohol problems in the clinics will be analyzed, comparing baseline levels to active (post-implementation) levels. Data: register based Level: practices Blood variables: Gamma-Glutamyltransferase (GGT) and Alanine-Aminotransferase (ALAT).
Eligibility Criteria
Criteria
Inclusion Criteria:
-
18 years or older
-
Affiliated with the participating general practices
Exclusion Criteria:
- None
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Unit for Clinical Alcohol Research, Clinical Institute, University of Southern Denmark | Odense C | Fynen | Denmark | 5000 |
Sponsors and Collaborators
- University of Southern Denmark
Investigators
- Study Director: Anette S Nielsen, Professor, Unit of Clinical Alcohol Research, University of Southern Denmark
- Principal Investigator: Jens Søgaard, Professor, Research Unit of General Practice Odense, University of Southern Denmark
Study Documents (Full-Text)
None provided.More Information
Additional Information:
- The iTAPP project website at The university of Southern Denmark (in Danish)
- The 15-method material and educational videos (Danish version) for participating healthcare professionals
Publications
None provided.- iTAPP project